Skip to Main Content

Author Details

Paul C Boutros
University of California los angeles
0000-0003-0553-7520
1970
345
66
Timothy Clark (CM4AI)
PMIDPaper TitleJournal TitlePublished Year
36097168Prospective comparison of restriction spectrum imaging and non-invasive biomarkers to predict upgrading on active surveillance prostate biopsy.Prostate Cancer Prostatic Dis2024
38059331HPV-negative head and neck cancers with adverse pathological features carry specific molecular changes that are associated with survival.Head Neck2024
35317874Establishment of four head and neck squamous cell carcinoma cell lines: importance of reference DNA for accurate genomic characterisation.J Laryngol Otol2023
37651670Pan-Cancer Analysis of Postdiagnosis Exercise and Mortality.J Clin Oncol2023
37546794Prostate Cancer Reshapes the Secreted and Extracellular Vesicle Urinary Proteomes.bioRxiv2023
38049604Prostate lineage-specific metabolism governs luminal differentiation and response to antiandrogen treatment.Nat Cell Biol2023
37778229Loss of LRP1B expression drives acquired chemo and radio-resistance in HPV-positive head and neck cancer.Oral Oncol2023
37815914MYC is a regulator of androgen receptor inhibition-induced metabolic requirements in prostate cancer.Cell Rep2023
37292676The landscape of drug sensitivity and resistance in sarcoma.bioRxiv2023
37126232Multimodal Biomarkers That Predict the Presence of Gleason Pattern 4: Potential Impact for Active Surveillance.J Urol2023
37188783Oncolytic DNX-2401 virotherapy plus pembrolizumab in recurrent glioblastoma: a phase 1/2 trial.Nat Med2023
37345203Serrate RNA Effector Molecule (SRRT) Is Associated with Prostate Cancer Progression and Is a Predictor of Poor Prognosis in Lethal Prostate Cancer.Cancers (Basel)2023
37171636Correction: Increased mRNA expression of CDKN2A is a transcriptomic marker of clinically aggressive meningiomas.Acta Neuropathol2023
36610996A polygenic two-hit hypothesis for prostate cancer.J Natl Cancer Inst2023
36870853Transcriptomic Heterogeneity in High-risk Prostate Cancer and Implications for Extraprostatic Disease at Presentation on Prostate-specific Membrane Antigen Positron Emission Tomography.Eur Urol Oncol2023
36773955Fumarate Hydratase Variants and Their Association With Paraganglioma/Pheochromocytoma.Urology2023
36449563Single-Cell Analysis in Lung Adenocarcinoma Implicates RNA Editing in Cancer Innate Immunity and Patient Prognosis.Cancer Res2023
36179990External Beam Radiation Therapy With or Without Brachytherapy Boost in Men With Very-High-Risk Prostate Cancer: A Large Multicenter International Consortium Analysis.Int J Radiat Oncol Biol Phys2023
32605887Determining the Impact of Spatial Heterogeneity on Genomic Prognostic Biomarkers for Localized Prostate Cancer.Eur Urol Oncol2022
35506245Impact of Exercise on Susceptibility and Severity of COVID-19 in Patients with Cancer: A Retrospective Study.Cancer Epidemiol Biomarkers Prev2022
35505417Prostate cancer multiparametric magnetic resonance imaging visibility is a tumor-intrinsic phenomena.J Hematol Oncol2022
35437583Methylation Subtypes of Primary Prostate Cancer Predict Poor Prognosis.Cancer Epidemiol Biomarkers Prev2022
35697807Estimation of tumor cell total mRNA expression in 15 cancer types predicts disease progression.Nat Biotechnol2022
35393414Virally programmed extracellular vesicles sensitize cancer cells to oncolytic virus and small molecule therapy.Nat Commun2022
36442320Immune-based classification of HPV-associated oropharyngeal cancer with implications for biomarker-driven treatment de-intensification.EBioMedicine2022
36481658Author Correction: Integrative pathway enrichment analysis of multivariate omics data.Nat Commun2022
36481612Author Correction: Divergent mutational processes distinguish hypoxic and normoxic tumours.Nat Commun2022
36108240Prostate Cancer Transcriptomic Regulation by the Interplay of Germline Risk Alleles, Somatic Mutations, and 3D Genomic Architecture.Cancer Discov2022
36178522The proteomic landscape of glioblastoma recurrence reveals novel and targetable immunoregulatory drivers.Acta Neuropathol2022
36103484Perish and publish: Dynamics of biomedical publications by deceased authors.PLoS One2022
36128328Targeting Krebs-cycle-deficient renal cell carcinoma with Poly ADP-ribose polymerase inhibitors and low-dose alkylating chemotherapy.Oncotarget2022
36327219Exome-wide association study to identify rare variants influencing COVID-19 outcomes: Results from the Host Genetics Initiative.PLoS Genet2022
36219881Minimal information for reporting a genomics experiment.Blood2022
36251389The 5-Hydroxymethylcytosine Landscape of Prostate Cancer.Cancer Res2022
35187756Tumor molecular differences associated with outcome disparities of Black patients with head and neck cancer.Head Neck2022
35119778Optimization of small extracellular vesicle isolation from expressed prostatic secretions in urine for in-depth proteomic analysis.J Extracell Vesicles2022
35265837Data-driven identification of inherent features of eukaryotic stress-responsive genes.NAR Genom Bioinform2022
35050303Interplay Between Duration of Androgen Deprivation Therapy and External Beam Radiotherapy With or Without a Brachytherapy Boost for Optimal Treatment of High-risk Prostate Cancer: A Patient-Level Data Analysis of 3 Cohorts.JAMA Oncol2022
35017538Age influences on the molecular presentation of tumours.Nat Commun2022
34724198Fumarate hydratase variant prevalence and manifestations among individuals receiving germline testing.Cancer2022
34774650Refining the definition of biochemical failure in the era of stereotactic body radiation therapy for prostate cancer: The Phoenix definition and beyond.Radiother Oncol2022
34175923Serological abnormalities that predict progression to systemic autoimmune rheumatic diseases in antinuclear antibody-positive individuals.Rheumatology (Oxford)2022
32972793Distinguishing Benign Renal Tumors with an Oncocytic Gene Expression (ONEX) Classifier.Eur Urol2021
33795785Transcriptional perturbation of protein arginine methyltransferase-5 exhibits MTAP-selective oncosuppression.Sci Rep2021
33741908CRISPRi screens reveal a DNA methylation-mediated 3D genome dependent causal mechanism in prostate cancer.Nat Commun2021
33725617All HPV-negative head and neck cancers are not the same: Analysis of the TCGA dataset reveals that anatomical sites have distinct mutation, transcriptome, hypoxia, and tumor microenvironment profiles.Oral Oncol2021
34919800HLA-A<sup>⿿</sup>02:01 restricted T cell receptors against the highly conserved SARS-CoV-2 polymerase cross-react with human coronaviruses.Cell Rep2021
34964855Comparison of Response to Definitive Radiotherapy for Localized Prostate Cancer in Black and White Men: A Meta-analysis.JAMA Netw Open2021
34902034Performance of a Prostate-Specific Membrane Antigen Positron Emission Tomography/Computed Tomography-Derived Risk-Stratification Tool for High-risk and Very High-risk Prostate Cancer.JAMA Netw Open2021
34824250The telomere length landscape of prostate cancer.Nat Commun2021
  • 1 - 50 of 345

Recommended Authors

Siyuan Zheng
Greehey Children's Cancer Research Institute
Career Start Year 2007
Number of shared co-authors 45
Ritu Roy
University of California San Francisco.
Career Start Year 2007
Number of shared co-authors 11
James C Costello
University of Colorado Anschutz Medical Campus
Career Start Year 2006
Number of shared co-authors 24
Matthew D Wilkerson
Uniformed Services University of the Health Sciences
Career Start Year 2004
Number of shared co-authors 49
Nathalie Pochet
Broad Institute of MIT and Harvard
Career Start Year 2004
Number of shared co-authors 3
Steffen Durinck
Genentech Inc.
Career Start Year 2004
Number of shared co-authors 12
Leslie Cope
Johns Hopkins University School of Medicine
Career Start Year 2003
Number of shared co-authors 22
Olivier Harismendy
University of California
Career Start Year 2003
Number of shared co-authors 14
Jianmin Wang
Roswell Park Comprehensive Cancer Center
Career Start Year 2003
Number of shared co-authors 9
Obi L Griffith
Washington University
Career Start Year 2003
Number of shared co-authors 49
Amy G Robertson
Present address: Dxige Research Inc.
Career Start Year 2003
Number of shared co-authors 78
Michael Slifker
Fox Chase Cancer Center
Career Start Year 2002
Number of shared co-authors 2
Joel S Parker
Lineberger Cancer Center, University of North Carolina
Career Start Year 2002
Number of shared co-authors 61
Olivier Elemento
Meyer Cancer Center
Career Start Year 2002
Number of shared co-authors 80
Mikhail G Dozmorov
Virginia Commonwealth University
Career Start Year 2001
Number of shared co-authors 2
Jean Yee Hwa Yang
The University of Sydney
Career Start Year 2001
Number of shared co-authors 1
Yidong Chen
The University of Texas Health Science Center at San Antonio
Career Start Year 2001
Number of shared co-authors 11
Yan W Asmann
Mayo Clinic
Career Start Year 2000
Number of shared co-authors 21
Andrea Sboner
Institute for Computational Biomedicine
Career Start Year 2000
Number of shared co-authors 92
Lodewyk F A Wessels
University Medical Centre Mannheim, University of Heidelberg
Career Start Year 2000
Number of shared co-authors 100
Shawn Levy
HudsonAlpha Institute for Biotechnology
Career Start Year 1999
Number of shared co-authors 30
Kerby Shedden
University of Michigan ann arbor
Career Start Year 1999
Number of shared co-authors 10
Celine Lefebvre
The Scripps Research Institute
Career Start Year 1999
Number of shared co-authors 8
Shannon K McWeeney
Oregon Health & Science University, University of California Berkeley
Career Start Year 1997
Number of shared co-authors 13
Wim Van Criekinge
Ghent University
Career Start Year 1995
Number of shared co-authors 25
Sudhir Varma
Center for Cancer Research, National Cancer Institute
Career Start Year 1994
Number of shared co-authors 7
Adam B Olshen
12224University of California san francisco
Career Start Year 1993
Number of shared co-authors 23
Keith A Baggerly
The University of Texas MD Anderson Cancer Center
Career Start Year 1991
Number of shared co-authors 26
Kevin R Coombes
Medical College of Georgia
Career Start Year 1990
Number of shared co-authors 25
Luigi Marchionni
Weill-Cornell School of Medicine
Career Start Year 1989
Number of shared co-authors 38

Collaborators

Robert G Bristow
University of Toronto
Co-authored papers 52
Michael Fraser
Princess Margaret Cancer Centre, University Health Network
Co-authored papers 42
Stephenie D Prokopec
University Health Network
Co-authored papers 35
Theodorus H van der Kwast
University Health Network, University of Toronto
Co-authored papers 33
Raimo Pohjanvirta
Department of Food Hygiene and Environmental Health, University of Helsinki
Co-authored papers 30
Cindy Q Yao
Ontario Institute for Cancer Research
Co-authored papers 27
Julie Livingstone
University of California los angeles
Co-authored papers 27
Allan B Okey
University of Toronto
Co-authored papers 27
Syed Haider
Institute of Cancer Research
Co-authored papers 25
Linda Z Penn
University of Toronto
Co-authored papers 24
Maud H W Starmans
Ontario Institute for Cancer Research
Co-authored papers 24
Igor Jurisica
Schroeder Arthritis Institute
Co-authored papers 23
Takafumi N Yamaguchi
University of California los angeles
Co-authored papers 22
Anthony C Nichols
University of Western Ontario
Co-authored papers 22
Kathleen E Houlahan
University of California los angeles
Co-authored papers 22
Thomas Kislinger
Princess Margaret Cancer Centre, University Health Network, University of Toronto
Co-authored papers 21
John W Barrett
University of Western Ontario
Co-authored papers 21
Joe S Mymryk
University of Western Ontario
Co-authored papers 20
Vincent Huang
Ontario Institute for Cancer Research
Co-authored papers 20
John D Watson
Ontario Institute for Cancer Research
Co-authored papers 19
Emilie Lalonde
University of Pennsylvania
Co-authored papers 18
John Yoo
Schulich School of Medicine & Dentistry, Western University
Co-authored papers 18
Yu-Jia Shiah
Ontario Institute for Cancer Research
Co-authored papers 17
Kevin Fung
Schulich School of Medicine & Dentistry, Western University, Victoria Hospital
Co-authored papers 17
Ivy D Moffat
University of Toronto
Co-authored papers 16
Stephanie Danielle MacNeil
Schulich School of Medicine and Dentistry, Western University
Co-authored papers 16
Felix Y Feng
UCSF Medical Center-Mount Zion
Co-authored papers 16
Alejandro Berlin
University of Toronto, Princess Margaret Cancer Centre
Co-authored papers 16
Philippe Lambin
Maastricht University
Co-authored papers 16
David A Palma
University of Western Ontario
Co-authored papers 15
Release 1.2